Literature DB >> 25843397

Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).

Bo Yi1, Juan Jiang1, Liyong Zhu1, Pengzhou Li1, Ibrahim Im2, Shaihong Zhu3.   

Abstract

OBJECTIVE: Based on distinct epidemiologic features of Chinese type 2 diabetes mellitus (T2DM) patients, who tend to have abdominal fat deposition, but with normal or mildly overweight epidemiologic features, our center initially had treated T2DM with body mass index (BMI)<35 kg/m² by performing laparoscopic Roux-en-Y gastrojejunostomy since 2008. This procedure is successful in treating abnormal glucose metabolism but not in improving abdominal visceral obesity. However, since 2011, laparoscopic Roux-Y gastric bypass (LRYGB) with a small stomach pouch has been performed at our center, with prominent resolution of abdominal visceral obesity and lower incidences of postoperative complications. The purpose of the present study was to formally compare these different procedures.
METHODS: From 2011 to 2013, 60 patients who met the NIH criteria were recruited and randomly assigned to undergo either laparoscopic Roux-en-Y gastrojejunostomy (n = 30) or LRYGB with a small stomach pouch (n = 30). All of the patients were followed for 12 months, and pre- and postoperative changes in BMI, waist circumference, fasting plasma glucose (FPG), postprandial plasma glucose (PBG), glycated hemoglobin (HbA1c), homoeostatic model assessment (HOMA-IR), the body fat rate and major complications were recorded.
RESULTS: Both procedures were successful in reducing HbA1c, FPG, and PBG levels and HOMA-IR scores. However, LRYGB with a small stomach pouch resulted in a greater reduction in FPG, PBG, and HbA1c levels, and HOMA-IR scores compared with Roux-en-Y gastrojejunostomy. In addition, the reductions in BMI, body fat content, waist circumference, and the incidence of postoperative marginal ulcers in the small-stomach-pouch LRYGB were significant.
CONCLUSIONS: Both procedures are effective treatments for T2DM patients with BMI<35 kg/m². However, the advantages of resolved abnormal glucose metabolism and abdominal visceral obesity and decreased incidences of surgical complications are more obvious for LRYGB with a small gastric pouch. Potentially, LRYGB with a small gastric pouch is more suitable for Chinese diabetic patients with BMI <35 kg/m².
Copyright © 2015 American Society for Bariatric Surgery. All rights reserved.

Entities:  

Keywords:  Abdominal visceral obesity; Insulin resistance; Laparoscopic Roux-en-Y gastric bypass (LRYGB); Stomach pouch; T2DM with BMI<35 kg/m²

Mesh:

Year:  2015        PMID: 25843397     DOI: 10.1016/j.soard.2014.12.029

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  6 in total

1.  A systematic review of the effect of gastric pouch and/or gastrojejunostomy (stoma) size on weight loss outcomes with Roux-en-Y gastric bypass.

Authors:  Kamal Mahawar; Alistair J Sharples; Yitka Graham
Journal:  Surg Endosc       Date:  2019-11-19       Impact factor: 4.584

2.  It's the Width Not the Size of the Pouch That Matters.

Authors:  Kamal K Mahawar
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

3.  The Effects of Bariatric Surgery on Type 2 Diabetes in Asian Populations: a Meta-analysis of Randomized Controlled Trials.

Authors:  Jin Hwa Kim; Jung-Soo Pyo; Won Jin Cho; Sang Yong Kim
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

4.  Ongoing Inconsistencies in Weight Loss Reporting Following Bariatric Surgery: a Systematic Review.

Authors:  Valentin Mocanu; Awrad Nasralla; Jerry Dang; Mack Jacobson; Noah Switzer; Karen Madsen; Daniel W Birch; Shahzeer Karmali
Journal:  Obes Surg       Date:  2019-04       Impact factor: 4.129

5.  Large Versus Small Gastric Pouch for Roux-en-Y Gastric Bypass in Individuals With Type 2 Diabetes and a Body Mass Index < 35 kg/m2: Six-Year Outcomes.

Authors:  Xiang Gao; Song Dai; Guohui Wang; Weizheng Li; Zhi Song; Zhihong Su; Shaihong Zhu; Liyong Zhu; Pengzhou Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-01       Impact factor: 6.055

Review 6.  Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis.

Authors:  Zhiyong Dong; Sheikh Mohammed Shariful Islam; Ashley M Yu; Rui Qu; Bingsheng Guan; Junchang Zhang; Zhao Hong; Cunchuang Wang
Journal:  BMC Surg       Date:  2018-09-17       Impact factor: 2.102

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.